Literature DB >> 16085689

Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer.

H J Huang1, P Neven, M Drijkoningen, R Paridaens, H Wildiers, E Van Limbergen, P Berteloot, F Amant, I Vergote, M R Christiaens.   

Abstract

BACKGROUND: In breast cancer, there is an inverse relationship between HER2/neu overexpression and receptors for estrogen (ER) or progesterone (PR). Some clinical observations such as the age-related association between hormone receptors and tumour grade, which predicts HER2/neu overexpression, suggest an age-related relationship. PATIENTS AND METHODS: Our study population consisted of 1362 consecutive women receiving primary surgery for non-metastatic invasive breast cancer. We compared the relationship between both hormone receptors and HER2/neu overexpression in different age groups taking other tumour characteristics into account.
RESULTS: In a multivariate model, considering the overall group, a negative ER, a negative PR and a high tumour grade were predictive for HER2/neu overexpression (P <0.001). Considering 246 women aged < or =45 years, the only predictor for HER2/neu overexpression in this age category was a high tumour grade (P = 0.003). Considering the 1116 women aged >45 years, ER (P = 0.001), PR (P = 0.001) and tumour grade (P <0.001) were associated with HER2/neu (P <0.001).
CONCLUSION: Our findings indicate that the association between ER, PR and HER2/neu overexpression varies with age. The hormone receptors are not an independent predictor for the HER2/neu status in young women while they are in elder patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085689     DOI: 10.1093/annonc/mdi364

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  22 in total

1.  Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA Quality Assurance Program.

Authors:  Glenn D Francis; Margaret Dimech; Leanne Giles; Alison Hopkins
Journal:  J Clin Pathol       Date:  2007-01-26       Impact factor: 3.411

2.  Role of ERRF, a novel ER-related nuclear factor, in the growth control of ER-positive human breast cancer cells.

Authors:  Dan Su; Xiaoying Fu; Songqing Fan; Xiao Wu; Xin-Xin Wang; Liya Fu; Xue-Yuan Dong; Jianping Jenny Ni; Li Fu; Zhengmao Zhu; Jin-Tang Dong
Journal:  Am J Pathol       Date:  2012-03       Impact factor: 4.307

3.  Correlation of ER, PR and HER-2/Neu with other Prognostic Factors in Infiltrating Ductal Carcinoma of Breast.

Authors:  Sepideh Siadati; Majid Sharbatdaran; Novin Nikbakhsh; Naser Ghaemian
Journal:  Iran J Pathol       Date:  2015

4.  A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China.

Authors:  Peng Xing; Jiguang Li; Feng Jin
Journal:  Med Oncol       Date:  2009-09-23       Impact factor: 3.064

5.  Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss.

Authors:  José Manuel Fernández-Real; Javier A Menendez; Gema Frühbeck; José María Moreno-Navarrete; Alejandro Vazquez-Martín; Wifredo Ricart
Journal:  Nutr Metab (Lond)       Date:  2010-02-25       Impact factor: 4.169

6.  Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.

Authors:  Muhammad Afzal; Mohammed Amir; Muhammad Jawad Hassan; Muhammad Sikander Hussain; Muhammad Naveed Aziz; Sheeba Murad; Iram Murtaza; Mariam Anees; Aneesa Sultan
Journal:  Tumour Biol       Date:  2016-01-06

7.  Study of hormone receptors and epidermal growth factor expression in invasive breast cancers in a cohort of Western India.

Authors:  Hardik Dodiya; Amit Patel; Dipal Patel; Ashish Kaushal; D G Vijay
Journal:  Indian J Clin Biochem       Date:  2013-01-03

8.  Association between hormone receptors and HER-2/neu is age-related.

Authors:  Bo Wang; Xiaoling Wang; Yinying Zou
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

9.  HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancer.

Authors:  Christian F Singer; Daphne Gschwantler-Kaulich; Anneliese Fink-Retter; Georg Pfeiler; Ingrid Walter; Gernot Hudelist; Samir Helmy; Anne-Catherine Spiess; Wolfgang Lamm; Ernst Kubista
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-26       Impact factor: 4.553

10.  Expression of estrogen receptor alpha with a Tet-off adenoviral system induces G0/G1 cell cycle arrest in SKBr3 breast cancer cells.

Authors:  Jing Peng; V Craig Jordan
Journal:  Int J Oncol       Date:  2010-02       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.